SCHEMBL7920896

SCHEMBL7920896

O=C(O)c1ccc2c(ccn2CC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 2/20 0.46
TUBB4A P04350 2/20 0.43
TUBB P07437 2/20 0.43
TUBA3C P0DPH7 2/20 0.43
TUBA1B P68363 2/20 0.43
TUBA4A P68366 2/20 0.43
TUBB4B P68371 2/20 0.43
TUBB3 Q13509 2/20 0.43
TUBB2A Q13885 2/20 0.43
TUBB8 Q3ZCM7 2/20 0.43
TUBA3E Q6PEY2 2/20 0.43
TUBA1A Q71U36 2/20 0.43
TUBA1C Q9BQE3 2/20 0.43
TUBB6 Q9BUF5 2/20 0.43
TUBB2B Q9BVA1 2/20 0.43
TUBB1 Q9H4B7 2/20 0.43
PLG P00747 2/20 0.42
PLAU P00749 2/20 0.42
RAPGEF4 Q8WZA2 1/20 0.42
PPARA Q07869 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30098926 0.87 PLAU (0.48) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5070880 0.85 PLA2G4A (0.48) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5387474 0.83 TUBB4A (0.59) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL5068315 0.81 TUBB4A (0.57) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL28607801 0.80 KMT2A (0.60) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL2983210 0.80 PLA2G4A (0.48) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL698712 0.79 HDAC8 (0.46) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL1664063 0.78 PLG (0.51) PLA2G4ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL30098981 0.78 HRH3 (0.55) PLA2G4A
SCHEMBL30098954 0.78 HPGD (0.52) HDAC8HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416638-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV Pharmaceuticals, Inc. (US) 2018-12-26 EP disclosed
WO-2017143291-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2017-08-24 WO disclosed
US-6228868-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-08 US disclosed
WO-2000006556-A1 SUBSTITUTED OXAZOLINES AS ANTIPROLIFERATIVE AGENTS ABBOTT LABORATORIES (US) 2000-02-10 WO disclosed